Offer - Urjas Oil for just ₹ 1 X
Kaptragin Mr is an allopathic medicine The correct dosage of Kaptragin Mr depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Kaptragin Mr is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Kaptragin Mr safe for pregnant women?
Pregnant women can take Kaptragin Mr safely.
Is the use of Kaptragin Mr safe during breastfeeding?
Kaptragin Mr is completely safe for breastfeeding women.
What is the effect of Kaptragin Mr on the Kidneys?
Kaptragin Mr may have mild side effects on the kidneys.
What is the effect of Kaptragin Mr on the Liver?
There may be an adverse effect on the liver after taking Kaptragin Mr. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Kaptragin Mr on the Heart?
Side effects of Kaptragin Mr rarely affect the heart.
Kaptragin Mr should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Kaptragin Mr unless your doctor advises you to do so -
Is this Kaptragin Mr habit forming or addictive?
Kaptragin Mr does not cause addiction.
Interaction between Food and Kaptragin Mr
Due to a lack of research, nothing can be said about the consequences of taking Kaptragin Mr together with food.
Interaction between Alcohol and Kaptragin Mr
Taking alcohol with Kaptragin Mr can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 357
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)